MCL1 and neoplasm: Concurrently, research by Zhang et al. (49) demonstrated that genistein-treated tumor-transplanted nude mice exhibited reduced tumor growth, coupled with a dose-dependent downregulation of MCL1, APP, and KDR protein and mRNA.